Related Experiment Video
Updated: May 13, 2026

A Method for Targeted 16S Sequencing of Human Milk Samples
Published on: March 23, 2018
A Systematic Review on the Impact of Donor Characteristics and Donor Milk Handling on Infant Health and Growth
Daniel Klotz1, Agnieszka Bzikowska-Jura2, Marzia Giribaldi3
1Bethel Center for Pediatrics, Department of Neonatology and Pediatric Intensive Care Medicine, University Hospital OWL, University of Bielefeld, Bielefeld, Germany.
Insights
Evidence on donor human milk (DHM) for premature infants is limited. This systematic review found insufficient data on DHM characteristics and treatments to guide clinical use and optimize infant health outcomes.
Area of Science:
- Neonatal nutrition
- Human milk research
- Infant health outcomes
Background:
- Global guidelines recommend donor human milk (DHM) for premature infants.
- Limited evidence exists on how donor characteristics and DHM processing affect infant health and growth.
Conclusions:
- Substantial evidence gaps exist regarding DHM treatments and premature infant outcomes.
- Prioritizing research on clinical outcomes is crucial for milk banking policies.
- Further investigation needed to support evidence-based DHM practices.
Abstract:
Global recommendations advocate the conditional use of donor human milk (DHM), yet evidence on the influence of donor characteristics and DHM treatment on premature infants' health and growth is lacking. This study aimed to compare clinical outcomes of infants fed standard DHM compared with modified DHM-based on predefined variations. We performed a systematic review searching 14 databases alongside clinical trial registries, up to 8 March, 2024. Any study designs, but case or animal studies, conference proceedings, reviews, and gray literature were included. Findings were synthesized narratively and in tables. Of 14,979 screened studies, 14 met inclusion criteria comparing clinical effects of DHM from mothers who gave birth prematurely compared with at term, DHM that was treated with high-temperature pasteurization methods compared with standard holder pasteurization, and concentrated or homogenized DHM compared with standard DHM. Our analysis revealed a significant paucity of clinical data for several interventions and a complete lack of evidence for most of our research questions, indicating insufficient evidence to support the clinical use and efficacy of the aforementioned interventions. We found substantial evidence gaps in understanding how DHM treatments influence health and growth in premature infants. Research prioritizing clinical outcomes is essential to guide milk-banking policies. The protocol was registered on PROSPERO as CRD42024522015.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
04:16Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota